| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8528514 | Clinical Therapeutics | 2017 | 9 Pages |
Abstract
No differences existed between HBOT and ST with respect to the incidence of healed ulcers, risk of minor or major amputations, and adverse events. HBOT was associated with a greater reduction in the ulcer wound area than ST. HBOT is a clinically meaningful adjuvant therapy for patients with diabetic foot ulcer.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Di MD, Shaowei MD, Wencan MD, Jun MD, Shaoda MD, Nasui MD,